Data from the Arimidex, tamoxifen, alone or in combination (ATAC) trial: implications for use of aromatase inhibitors in 2003.
about
Natural products as aromatase inhibitorsChanges in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozoleRole of aromatase inhibitors in breast cancer.Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up.Estrogen receptors: role in breast cancer.
P2860
Data from the Arimidex, tamoxifen, alone or in combination (ATAC) trial: implications for use of aromatase inhibitors in 2003.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Data from the Arimidex, tamoxi ...... aromatase inhibitors in 2003.
@ast
Data from the Arimidex, tamoxi ...... aromatase inhibitors in 2003.
@en
type
label
Data from the Arimidex, tamoxi ...... aromatase inhibitors in 2003.
@ast
Data from the Arimidex, tamoxi ...... aromatase inhibitors in 2003.
@en
prefLabel
Data from the Arimidex, tamoxi ...... aromatase inhibitors in 2003.
@ast
Data from the Arimidex, tamoxi ...... aromatase inhibitors in 2003.
@en
P1476
Data from the Arimidex, tamoxi ...... aromatase inhibitors in 2003.
@en
P2093
Aman U Buzdar
P304
P356
10.1158/1078-0432.CCR-031203
P407
P433
P577
2004-01-01T00:00:00Z